Araz, M. Et Al. 2023. The Role of (18)F-FDOPA PET/CT in Recurrent Medullary Thyroid Cancer Patients with Elevated Serum Calcitonin Levels.. Molecular imaging and radionuclide therapy , vol.32, no.1 , 1-7.

Araz, M., Soydal, Ç., Demir, Ö., Gökcan, M. K., & Küçük, N. Ö., (2023). The Role of (18)F-FDOPA PET/CT in Recurrent Medullary Thyroid Cancer Patients with Elevated Serum Calcitonin Levels.. Molecular imaging and radionuclide therapy , vol.32, no.1, 1-7.

Araz, MİNE Et Al. "The Role of (18)F-FDOPA PET/CT in Recurrent Medullary Thyroid Cancer Patients with Elevated Serum Calcitonin Levels.," Molecular imaging and radionuclide therapy , vol.32, no.1, 1-7, 2023

Araz, MİNE Et Al. "The Role of (18)F-FDOPA PET/CT in Recurrent Medullary Thyroid Cancer Patients with Elevated Serum Calcitonin Levels.." Molecular imaging and radionuclide therapy , vol.32, no.1, pp.1-7, 2023

Araz, M. Et Al. (2023) . "The Role of (18)F-FDOPA PET/CT in Recurrent Medullary Thyroid Cancer Patients with Elevated Serum Calcitonin Levels.." Molecular imaging and radionuclide therapy , vol.32, no.1, pp.1-7.

@article{article, author={MİNE ARAZ Et Al. }, title={The Role of (18)F-FDOPA PET/CT in Recurrent Medullary Thyroid Cancer Patients with Elevated Serum Calcitonin Levels.}, journal={Molecular imaging and radionuclide therapy}, year=2023, pages={1-7} }